Pipe and Cigar Smoking Linked to Lung Decline and Increased Health Risks

For years, pipe and cigar smoking have often been perceived as a safer alternative to cigarettes. However, emerging evidence challenges this assumption. A comprehensive analysis of long-running U.S. Cohort studies reveals that pipe and cigar smoking is associated with accelerated lung function decline and increased risks of death and serious respiratory outcomes, even among individuals who have never smoked cigarettes.

The Persistent Threat of Tobacco Use

Smoking tobacco remains a leading cause of heart and lung disease globally. Although cigarette smoking has been extensively researched, the long-term health effects of pipe and cigar smoking have received comparatively less attention, despite their continued prevalence among adults. This recent analysis aims to address this gap by examining lung health and clinical outcomes over several decades.

Pipe and Cigar Smoking and Lung Function Loss

Researchers analyzed data from over 22,000 adults enrolled between 1971 and 2011, with follow-up continuing through 2018. Lung function was assessed using spirometry, a standard clinical practice that measures forced expiratory volume in one second (FEV1) and forced vital capacity.

Compared to individuals who had never used tobacco, exclusive pipe and cigar smokers experienced a faster annual decline in lung function. This reduction affected both airflow and lung volume, along with a gradual worsening of the ratio used to identify obstructive lung disease. Even modest yearly losses in lung function can accumulate over time, increasing vulnerability to chronic lung conditions. Specifically, exclusive pipe/cigar use was associated with a decline of 3.36 mL/year in FEV1, 3.73 mL/year in FVC, and a decrease of 0.031 per year in the FEV1/FVC ratio Thorax.

Increased Risks of Mortality and Chronic Lung Disease

Beyond lung function decline, pipe and cigar smoking was linked to poorer clinical outcomes. Exclusive users had a higher risk of all-cause mortality, with an adjusted hazard ratio (aHR) of 1.24 (95% CI 1.08 to 1.41). They were also more than twice as likely to experience hospitalization or death related to chronic obstructive pulmonary disease (COPD), with an aHR of 2.02 (95% CI 1.41 to 2.90). They were more likely to develop a spirometry pattern associated with impaired lung health despite preserved airflow ratios PubMed.

Importantly, these associations were observed even in individuals with no history of cigarette smoking, indicating that the risks are not solely attributable to prior cigarette exposure EMJ Reviews.

Implications for Prevention and Clinical Practice

These findings reinforce that pipe and cigar smoking is not a harmless habit. Clinically, they emphasize the importance of inquiring about all forms of tobacco use, not just cigarettes, when assessing respiratory risk. At a population level, the results support stronger prevention and cessation efforts targeting non-cigarette tobacco products.

While this study cannot definitively prove cause and effect, the consistent pattern of lung function changes and adverse outcomes over long follow-up periods underscores the potential harm of pipe and cigar smoking, challenging the perception of relative safety.

Key Takeaways

• Pipe and cigar smoking is associated with accelerated lung function decline.
• Exclusive pipe and cigar smokers face increased risks of mortality and COPD.
• These risks are present even in individuals who have never smoked cigarettes.
• Healthcare providers should inquire about all forms of tobacco use.
• Prevention and cessation efforts should target all tobacco products, not just cigarettes.

Reference: Gardner WM et al. Pipe and cigar use, lung function decline and clinical outcomes: an analysis of the NHLBI Pooled Cohorts Study. Thorax. 2026; DOI:10.1136/thorax-2025-224461.